drugset / Trial / NCT06180889
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
RandomizedParallel-groupOpen-labelPrevention
Summary
This study was to compare the study drug KN060 to enoxaparin, for the prevention of blood clotting and safety in patients undergoing total knee arthroplasty (TKA).
Timeline
- Start
- 2023-12-20
- Primary completion
- 2025-12-15
- Completion
- 2026-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | 40 mg | Subcutaneous |
| Subject | KN060 | Unknown | — | Intravenous |